About The Cover
The cover for issue 37 of Oncotarget features Figure 7, "Flow diagram illustrating doxorubicin and 5FU chemoresistance in breast cancer tumors," by Ullah, et al.
Table of Contents
Editorial
Organ preservation for T2-T3 rectal cancer: opportunistic or planned strategy
| Organ preservation for T2-T3 rectal cancer: opportunistic or planned strategy |
|
https://doi.org/10.18632/oncotarget.26916 Jéan-Pierre Gérard, Nicolas Barbet, and Karen Benezery |
| 3431-3432 |
| PDF | How to cite |
circPSMC3: ceRNA and tumor suppressor
| circPSMC3: ceRNA and tumor suppressor |
|
https://doi.org/10.18632/oncotarget.26953 Chen Lu, Dawei Rong, and Weiwei Tang |
| 3433-3434 |
| PDF | How to cite |
Priority Research Papers
Mesenchymal stem cells confer chemoresistance in breast cancer via a CD9 dependent mechanism
| Mesenchymal stem cells confer chemoresistance in breast cancer via a CD9 dependent mechanism |
|
https://doi.org/10.18632/oncotarget.26952 Mujib Ullah, Asma Akbar, Nathan Norton Ng, Waldo Concepcion, and Avnesh S. Thakor |
| 3435-3450 |
| Abstract | PDF | Full Text | How to cite |
Research Papers: Immunology
Endotoxin tolerance modulates TREG and TH17 lymphocytes protecting septic mice
| Endotoxin tolerance modulates TREG and TH17 lymphocytes protecting septic mice |
|
https://doi.org/10.18632/oncotarget.26919 Mariana M.C. Andrade, Suely S.K. Ariga, Denise F. Barbeiro, Hermes V. Barbeiro, Rosangela N. Pimentel, Ricardo C. Petroni, and Francisco G. Soriano |
| 3451-3461 |
| Abstract | PDF | Full Text | How to cite |
Research Papers
The histone deacetylase inhibitor Romidepsin induces as a cascade of differential gene expression and altered histone H3K9 marks in myeloid leukaemia cells
| The histone deacetylase inhibitor Romidepsin induces as a cascade of differential gene expression and altered histone H3K9 marks in myeloid leukaemia cells |
|
https://doi.org/10.18632/oncotarget.26877 Kathryn Clarke, Christine Young, Fabio Liberante, Mary-Frances McMullin, Alexander Thompson, and Ken Mills |
| 3462-3471 |
| Abstract | PDF | Full Text | Supplementary Information | How to cite |
Frankincense essential oil suppresses melanoma cancer through down regulation of Bcl-2/Bax cascade signaling and ameliorates heptotoxicity via phase I and II drug metabolizing enzymes
| Frankincense essential oil suppresses melanoma cancer through down regulation of Bcl-2/Bax cascade signaling and ameliorates heptotoxicity via phase I and II drug metabolizing enzymes |
|
https://doi.org/10.18632/oncotarget.26930 Faruck L. Hakkim, Hamid A. Bakshi, Shabia Khan, Mohamad Nasef, Rabia Farzand, Smitha Sam, Luay Rashan, Mohammed S. Al-Baloshi, Sidgi Syed Anwar Abdo Hasson, Ali Al Jabri, Paul A. McCarron, and Murtaza M. Tambuwala |
| 3472-3490 |
| Abstract | PDF | Full Text | How to cite |
IgG based immunome analyses of breast cancer patients reveal underlying signaling pathways
| IgG based immunome analyses of breast cancer patients reveal underlying signaling pathways |
|
https://doi.org/10.18632/oncotarget.26834 István Gyurján, Sandra Rosskopf, Johana A. Luna Coronell, Daniela Muhr, Christian Singer, and Andreas Weinhäusel |
| 3491-3505 |
| Abstract | PDF | Full Text | Supplementary Information | How to cite |
Comparative genomic analysis of driver mutations in matched primary and recurrent meningiomas
| Comparative genomic analysis of driver mutations in matched primary and recurrent meningiomas |
|
https://doi.org/10.18632/oncotarget.26941 Joshua Loewenstern, John Rutland, Corey Gill, Hanane Arib, Margaret Pain, Melissa Umphlett, Yayoi Kinoshita, Russell McBride, Michael Donovan, Robert Sebra, Joshua Bederson, Mary Fowkes, and Raj Shrivastava |
| 3506-3517 |
| Abstract | PDF | Full Text | Supplementary Information | How to cite |
Synergistic inhibition of tumor cell proliferation by metformin and mito-metformin in the presence of iron chelators
| Synergistic inhibition of tumor cell proliferation by metformin and mito-metformin in the presence of iron chelators |
|
https://doi.org/10.18632/oncotarget.26943 Gang Cheng, Jacek Zielonka, Micael Hardy, Olivier Ouari, Christopher R. Chitambar, Michael B. Dwinell, and Balaraman Kalyanaraman |
| 3518-3532 |
| Abstract | PDF | Full Text | Supplementary Information | How to cite |
Adaptive responses in a PARP inhibitor window of opportunity trial illustrate limited functional interlesional heterogeneity and potential combination therapy options
| Adaptive responses in a PARP inhibitor window of opportunity trial illustrate limited functional interlesional heterogeneity and potential combination therapy options |
|
https://doi.org/10.18632/oncotarget.26947 Marilyne Labrie, Tae-Beom Kim, Zhenlin Ju, Sanghoon Lee, Wei Zhao, Yong Fang, Yiling Lu, Ken Chen, Pedro Ramirez, Michael Frumovitz, Larissa Meyer, Nicole D. Fleming, Anil K. Sood, Robert L. Coleman, Gordon B. Mills, and Shannon N. Westin |
| 3533-3546 |
| Abstract | PDF | Full Text | Supplementary Information | How to cite |
In vitro and in vivo anti-tumor effects of brexpiprazole, a newly-developed serotonin-dopamine activity modulator with an improved safety profile
| In vitro and in vivo anti-tumor effects of brexpiprazole, a newly-developed serotonin-dopamine activity modulator with an improved safety profile |
|
https://doi.org/10.18632/oncotarget.26949 Shuhei Suzuki, Masahiro Yamamoto, Keita Togashi, Tomomi Sanomachi, Asuka Sugai, Shizuka Seino, Takashi Yoshioka, Chifumi Kitanaka, and Masashi Okada |
| 3547-3558 |
| Abstract | PDF | Full Text | How to cite |
Interleukin 1 is a key driver of inflammatory bowel disease-demonstration in a murine IL-1Ra knockout model
| Interleukin 1 is a key driver of inflammatory bowel disease-demonstration in a murine IL-1Ra knockout model |
|
https://doi.org/10.18632/oncotarget.26894 Rasha H. Dosh, Nicola Jordan-Mahy, Christopher Sammon, and Christine Le Maitre |
| 3559-3575 |
| Abstract | PDF | Full Text | Supplementary Information | How to cite |
Corrections
Correction: The role of substance P in epilepsy and seizure disorders
| Correction: The role of substance P in epilepsy and seizure disorders |
|
https://doi.org/10.18632/oncotarget.26991 Xue Feng Wang, Tong Tong Ge, Jie Fan, Wei Yang, Li Bingjin, and Ran Ji Cui |
| 3576-3576 |
| Correction | PDF | How to cite |
Correction: Metformin sensitizes anticancer effect of dasatinib in head and neck squamous cell carcinoma cells through AMPK-dependent ER stress
| Correction: Metformin sensitizes anticancer effect of dasatinib in head and neck squamous cell carcinoma cells through AMPK-dependent ER stress |
|
https://doi.org/10.18632/oncotarget.26997 Yu-Chin Lin, Meng-Hsuan Wu, Tzu-Tang Wei, Yun-Chieh Lin, Wen-Chih Huang, Liang-Yu Huang, Yi-Ting Lin, and Ching-Chow Chen |
| 3577-3578 |
| Correction | PDF | How to cite |
Copyright © 2025 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC